Patents by Inventor John E. Kerr

John E. Kerr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8071133
    Abstract: A method of making an oral dosage form of a water insoluble drug such as Saquinavir or Cyclosporine or Paclitaxel is carried out by: (a) providing a single phase working Solution comprising or consisting essentially of an active agent, water, a water-soluble polymer, and a solvent, said solvent selected from the group consisting of alcohol, acetone, and mixtures thereof; and may or may not contain a surfactant and pH of the said working solution may or may not be adjusted (b) providing particles formed from a pharmaceutically acceptable core material; (c) combining, preferably by spraying, said working solution with said particles to produce active agent-coated particles; such drug loaded particles may contain an external coat (d) drying said active agent-coated particles; and (e) forming said dried particles into an oral dosage form. Dried particles produced by the process, oral dosage forms containing such particles, and methods of treatment therewith are also described.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: December 6, 2011
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Ranga R. Namburi, Allen L. Lawson, John E. Kerr
  • Publication number: 20040052847
    Abstract: A method of making an oral dosage form of a water insoluble drug such as Saquinavir or Cyclosporine or Paclitaxel is carried out by: (a) providing a single phase working Solution comprising or consisting essentially of an active agent, water, a water-soluble polymer, and a solvent, said solvent selected from the group consisting of alcohol, acetone, and mixtures thereof; and may or may not contain a surfactant and pH of the said working solution may or may not be adjusted (b) providing particles formed from a pharmaceutically acceptable core material; (c) combining, preferably by spraying, said working solution with said particles to produce active agent-coated particles; such drug loaded particles may contain an external coat (d) drying said active agent-coated particles; and (e) forming said dried particles into an oral dosage form. Dried particles produced by the process, oral dosage forms containing such particles, and methods of treatment therewith are also described.
    Type: Application
    Filed: July 11, 2003
    Publication date: March 18, 2004
    Inventors: Ranga R. Namburi, Allen L. Lawson, John E. Kerr
  • Patent number: D1023009
    Type: Grant
    Filed: May 10, 2022
    Date of Patent: April 16, 2024
    Assignee: Apple Inc.
    Inventors: Jody Akana, Molly Anderson, Bartley K. Andre, Shota Aoyagi, Anthony Michael Ashcroft, John J. Baker, Marine C. Bataille, Jeremy Bataillou, Abidur Rahman Chowdhury, Clara Geneviève Marine Courtaigne, Markus Diebel, Richard Hung Minh Dinh, Christopher E. Glazowski, Jonathan Gomez Garcia, Jean-Pierre S. Guillou, M. Evans Hankey, Matthew David Hill, Julian Hoenig, Richard P. Howarth, Jonathan P. Ive, Julian Jaede, Duncan Robert Kerr, Peter Russell-Clarke, Benjamin Andrew Shaffer, Sung-Ho Tan, Clement Tissandier, Eugene Antony Whang, Rico Zörkendörfer